Boehringer Ingelheim Articles
Tiotropium ups exercise endurance in COPD
27 May 2002
Bayer seals exclusive rights to Novochem
20 May 2002
WHO "essential list" of malaria, AIDS drugs
6 May 2002
Japanese drug makers face foreign rivalry
29 April 2002
BI's Spiriva cleared for COPD in EU
22 April 2002
Parkinson's drugs may slow progression
22 April 2002
New president and chairman at Nippon Boeh Ingelheim
15 April 2002
Boeh Ingelheim reports 8.2% financial growth
15 April 2002
JV in Japanese animal health market
8 April 2002
GPC biotech revenues leap, net loss narrows
1 April 2002
S African govt slams nevirapine ruling
1 April 2002
Thailand producing AIDS triple-drug pill
1 April 2002
GPC biotech revenues leap, net loss narrows
1 April 2002
S African court OKs govt AIDS appeal
18 March 2002
23 members of BI's HIV donation program
18 March 2002
Boehringer Ingelheim opens China production site
11 March 2002
BI's tipranavir effective in resistant HIV
11 March 2002
Viramune is safe, says S African MRC
4 March 2002
South Africa HIV/AIDS spending to boost Viramune use in MTCT
25 February 2002
Drugmakers in Japan seek Rx-OTC switches
25 February 2002
New NICE appraisal program goes for one-month consultation
25 February 2002
Mandela slams Sth Africa govt on AIDS
25 February 2002
S African HIV/AIDS MTCT policy easing?
18 February 2002
Boeh Ingelheim in $80m deal to develop NeuroSearch drug
18 February 2002
S African doctors slam govt over nevirapine
11 February 2002
Julio Montaner gets C$1M Boeh Ingelheim HIV Award
11 February 2002
Tokyo pharma stocks - week to January 28
4 February 2002
BioTie to start trials of new anticoagulant
28 January 2002
S African state using nevirapine for MTCT
28 January 2002
Boeh Ingelheim and Structural sign HIV deal
7 January 2002
Boeh Ingelheim and Structural sign HIV deal
18 December 2001
Boehringer Ingelheim Viramune program
3 December 2001
HIV/AIDS patients "must get drug treatment," says Mandela
3 December 2001
S African drug supply row will go to court
20 November 2001
BI reports 96-week Viramune data
30 October 2001
TAC seeks to settle with S Africa govt
30 October 2001
Japan pharma stock market - week to October 15
17 October 2001
AIDS Rx price cuts "not enough:" pharma/UN
10 October 2001
Novartis' Foradil cleared for COPD in USA; new data on Xolair
27 September 2001
New Spiriva data reinforce profile of potential COPD blockbuster
26 September 2001
Global pulmonary drug delivery market forecasts
24 September 2001
InterMune switches Actimmune production
20 September 2001
Foradil tops standard therapy for COPD
19 September 2001
12 countries join BI's Viramune Donation Program
13 September 2001
Boeh Ingelheim hires Axios to expand Viramune access
7 September 2001
News of BI's new plant
6 September 2001
Solid first-half 2001 for Boeh Ingelheim
29 August 2001
InterMune completes Ph III IPF trial enrollment
23 August 2001
TAC sues S African govt over Viramune
22 August 2001
Boehringer Ingelheim appointment
26 July 2001
Cipla drops HIV/AIDS cocktail price in India
13 July 2001
Muff becomes non-executive chairman at BI UK
12 July 2001
DuPont's Sustiva tops PI therapy over 3 years
10 July 2001
BI's tipranavir effective as HIV salvage regimen
10 July 2001
UK MRC to fund Viramune study
3 July 2001
Tanzania: free Viramune for pregnant women
2 July 2001
Australia plans cheap HIV/AIDS drugs for Asia
2 July 2001
New president at Akorn
31 May 2001
Good start to 2001 for Germany's GPC Biotech
23 May 2001
South African generics maker's AIDS drug plan
21 May 2001
BI's tenecteplase launched in UK
21 May 2001
Cipla to supply Nigeria with HIV/AIDS drugs
9 May 2001
Boehringer Ingelheim reports sales, income up in 2000
25 April 2001
Mali, Cameroon to get cheap HIV/AIDS drugs
11 April 2001
New world market forecasts from DR
6 April 2001
IFPMA urges govts to act on drug distribution
6 April 2001
UN drug patent pledge in return for discounts
6 April 2001
EU to study pharma competitiveness
3 April 2001
Boehringer Ingelheim and Intermune link up on IFN gamma
29 March 2001
Boehringer's tipranavir shows early promise in HIV
15 March 2001
Ranbaxy to buy stake in German Remedies?
13 March 2001
Drug majors cut AIDS drug prices further
7 March 2001
Cipla talks with WHO over AIDS drug offer
1 March 2001
10 countries to get Cipla's AIDS drugs
26 February 2001
Kenyan moves to buy cheap AIDS drugs
26 February 2001
Indian firms eye Asta's German Remedies
19 February 2001
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
